As shown in Figure 3A and Supplementary Fig. S5B, CCN1 overexpression promoted the expression of CD44 and YKL40 in PN‐GSCs and GBM cell lines, indicating the MES differentiation. The gene discussed is CD44; the disease is glioblastoma.